143 related articles for article (PubMed ID: 36583252)
1. Efficacy and safety of total lymphoid irradiation in different chronic lung allograft dysfunction phenotypes.
Geng-Cahuayme AAA; Sáez-Giménez B; Altabas-González M; Vázquez-Varela M; Berastegui-Garcia C; Giralt-López de Sagredo J; Zapata-Ortega M; Recalde-Vizcay E; López-Meseguer M
Clin Transplant; 2023 Feb; 37(2):e14891. PubMed ID: 36583252
[TBL] [Abstract][Full Text] [Related]
2. Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation: a single-center experience and review of literature.
Lebeer M; Kaes J; Lambrech M; Vanstapel A; Beeckmans H; Ambrocio GPL; Vanaudenaerde BM; Verleden SE; Verbeken EK; Neyrinck AP; Ceulemans LJ; Van Raemdonck DE; Verleden GM; Vos R;
Transpl Int; 2020 Feb; 33(2):216-228. PubMed ID: 31643104
[TBL] [Abstract][Full Text] [Related]
3. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
Benden C; Haughton M; Leonard S; Huber LC
J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
[TBL] [Abstract][Full Text] [Related]
4. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation.
Fisher AJ; Rutherford RM; Bozzino J; Parry G; Dark JH; Corris PA
Am J Transplant; 2005 Mar; 5(3):537-43. PubMed ID: 15707408
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center study.
Verleden SE; Von Der Thüsen J; Van Herck A; Weynand B; Verbeken E; Verschakelen J; Dubbeldam A; Vanaudenaerde BM; Vos R; Verleden GM;
Clin Transplant; 2020 Feb; 34(2):e13781. PubMed ID: 31958356
[TBL] [Abstract][Full Text] [Related]
7. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
[TBL] [Abstract][Full Text] [Related]
8. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation.
Diamond DA; Michalski JM; Lynch JP; Trulock EP
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):795-800. PubMed ID: 9652840
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of total lymphoid irradiation in azithromycin nonresponsive chronic allograft rejection after lung transplantation.
Verleden GM; Lievens Y; Dupont LJ; Van Raemdonck DE; De Vleeschauwer SI; Vos R; Vanaudenaerde BM
Transplant Proc; 2009 Jun; 41(5):1816-20. PubMed ID: 19545735
[TBL] [Abstract][Full Text] [Related]
11. Validation of a post-transplant chronic lung allograft dysfunction classification system.
Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
[TBL] [Abstract][Full Text] [Related]
13. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
[TBL] [Abstract][Full Text] [Related]
14. Use of CT-SCAN score and volume measures to early identify restrictive allograft syndrome in single lung transplant recipients.
Philippot Q; Debray MP; Bun R; Frija-Masson J; Bunel V; Morer L; Roux A; Picard C; Jebrak G; Dauriat G; Castier Y; Cazes A; Mal H; Taupin JL; Couffignal C; Brugière O
J Heart Lung Transplant; 2020 Feb; 39(2):125-133. PubMed ID: 31836403
[TBL] [Abstract][Full Text] [Related]
15. Percentage of low attenuation area on computed tomography detects chronic lung allograft dysfunction, especially bronchiolitis obliterans syndrome, after bilateral lung transplantation.
Kubo Y; Sugimoto S; Shiotani T; Matsubara K; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Toyooka S
Clin Transplant; 2023 Nov; 37(11):e15077. PubMed ID: 37461238
[TBL] [Abstract][Full Text] [Related]
16. Chronic Lung Allograft Dysfunction.
Venado A; Kukreja J; Greenland JR
Thorac Surg Clin; 2022 May; 32(2):231-242. PubMed ID: 35512941
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
[TBL] [Abstract][Full Text] [Related]
18. Montelukast in chronic lung allograft dysfunction after lung transplantation.
Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
[TBL] [Abstract][Full Text] [Related]
19. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
[TBL] [Abstract][Full Text] [Related]
20. Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.
Gottlieb J; Verleden GM; Perchl M; Valtin C; Vallee A; Brugière O; Bravo C
PLoS One; 2021; 16(12):e0260881. PubMed ID: 34941934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
